Peptide therapeutics market global industry analysis, size, share, growth, trends

  • View
    197

  • Download
    3

Embed Size (px)

DESCRIPTION

Transparency Market Research is published new Market Report "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018" Browse full Report with TOC: http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Transcript

  • 1. Transparency Market ResearchPeptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 2018Buy Now Request SamplePublished Date: Mar 2013Single User License: US $ 4595 Multi User License: US $ 7595128 Pages ReportCorporate User License: US $ 10595REPORT DESCRIPTION Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 2018 The Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges

2. due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body. Likewise, peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses. This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 2018 in terms of value in USD million. The peptide therapeutics market is also segmented based on geography into North America, Europe, Asia and rest of the world (RoW) regions. The market for all these geographical regions is provided in the report in terms of revenue. The report provides complete analysis of the factors responsible for driving and restraining the global peptide therapeutics market. Competitive landscape is provided with market players profiled with attributes like company overview,financialoverview,businessstrategies,productportfolioandrecentdevelopments. Market shares in 2011 for the key players and CMO players are provided and recommendations to accentuate market shares and ensure sustainability are provided in this report Key market players profiled in this report are Eli Lilly, Roche, Amylin, NovoNordisk, Ipsen and others. While CMOs major players profiled are Bachem, Lonza, Peptisyntha, Polypeptide group and others. Peptide Therapeutics Market, by Applications CancerMetabolicCardiovascular 3. DermatologyAnti-InfectionNeurologyGastro IntestinalRenalRespiratoryPainOthersPeptide Therapeutics Market, by Route of Administration ParenteralOralPulmonaryMucosalOthersPeptide Therapeutics Market, by Types InnovativeGenericsPeptide Therapeutics Market, by API Peptide In-HouseCMO (Contract Manufacturing Organization)Peptide Therapeutics by Technology Liquid Phase Peptide Synthesis (LPPS)Solid Phase Peptide Synthesis (SPPS)Hybrid 4. Peptide Therapeutics Market, by Geography North AmericaEuropeAsiaRoWBrowse full Report with TOC: http://www.transparencymarketresearch.com/peptidetherapeutics-market.htmlTABLE OF CONTENTS Chapter 1 Introduction 1.1 Report description 1.2 Market segmentation 1.3 Scope of the report 1.4 Research methodology 1.5 AssumptionsChapter 2 Executive Summary 2.1 Global peptide therapeutics market revenues, 2010 2018 (USD Million) 2.1.1 Global peptide therapeutics market revenues, by region, 2010 - 2018 (USD Million)2.1.2 Global API peptide therapeutics market, 2011 (USD Million) 2.1.3 Global peptide therapeutics market, by route of administration, 2011 & 2018 (%) Related Reports: Pharmacy Automation Systems Market: http://www.transparencymarketresearch.com/pharmacy-automation-systems.html mHealth Market: http://www.transparencymarketresearch.com/mobile-healthmarket.html 5. Radiopharmaceuticals Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html Insulin Market: http://www.transparencymarketresearch.com/insulin-market.htmlChapter 3 Global Peptide Therapeutics Market Dynamics 3.1 Overview 3.2 Drivers 3.2.1 Increase in cancer patient population to propel the growth of new peptides 3.2.2 Rise in metabolic disorders to escalate the growth of peptides market 3.2.3 Rise in R&D pipeline of peptide drugs is expected to bring considerable growth in coming years 3.2.3.1 Global peptide therapeutics trials growth, 1970 - 2011 3.2.4 Technological enhancement has boosted the growth of the market with radical reduction in total production cost of peptides 3.3 Restraints & challenges 3.3.1 Increasing complexity of peptides is a huge challenge for manufacturers 3.3.2 Lack of regulatory standards hampering the growth of the market 3.3.3 Matching equipments with customer requirements is a major challenge for API peptide manufacturers 3.4 Opportunities 3.4.1 Rise in cancer vaccine to drive the future market 3.4.2 Generic peptides market to flourish with patent cliff expected in the forecast period3.4.3 Small biotech firms collaborating with large pharmaceutical companies to explore further growth 3.4.3.1 Global scenario of acquisitions of biotech firms by large pharma giants 3.4.3.2 Major peptide drugs and sales, 2011 (USD Million) 3.5 Porters five forces analysis 6. 3.5.1 Porters five forces analysis of global peptide therapeutics market 3.5.2 Bargaining power of suppliers 3.5.3 Bargaining power of buyers 3.5.4 Threat of new entrants 3.5.5 Threat of substitutes 3.5.6 Competitive rivalry 3.6 Market attractiveness analysis 3.6.1 Market attractiveness analysis of the peptide therapeutics market by geography 3.7 Peptide therapeutics - emerging technologies & trends 3.8 Regulatory policiesChapter 4 Global Peptide Therapeutics Market Analysis, By Applications 4.1 Introduction 4.1.1 Global peptide therapeutics market revenue, by applications 2012-2018 (USD Million)4.1.2 Cancer 4.1.2.1 Global cancer peptide therapeutics pipeline drugs analysis, number of trials, 2009 - 2012 4.1.2.2 Global cancer peptide therapeutics market revenues, 2010 2018 (USD Million)4.1.3 Metabolic 4.1.3.1 Global metabolic peptide therapeutics pipeline drugs analysis, number of trials, 2009 - 2012 4.1.3.2 Global metabolic peptide therapeutics market revenues, 2010 2018 (USD Million)4.1.4 Cardiovascular 4.1.4.1 Global cardiovascular peptide therapeutics pipeline drugs analysis, number of trials, 2009 - 2012 4.1.4.2 Global cardiovascular peptide therapeutics market revenues, 2010 2018 (USD Million) 7. 4.1.5 Dermatology 4.1.5.1 Global dermatology pipeline drugs analysis, number of trials, 2009 - 2012 4.1.5.2 Global dermatology peptides market revenues, 2010 2018 (USD Million) 4.1.6 Anti-Infection 4.1.6.1 Global anti-infection drugs analysis, number of trials, 2009 - 2012 4.1.6.2 Global anti-infection peptides market revenues, 2010 2018 (USD Million) 4.1.7 Neurology 4.1.7.1 Global neurology pipeline drugs analysis, number of trials, 2009 - 2012 4.1.7.2 Global neurology peptides market revenues, 2010 2018 (USD Million) 4.1.8 Gastro Intestinal 4.1.8.1 Global gastro intestinal pipeline drugs analysis, number of trials, 2009 - 2012 4.1.8.2 Global gastro intestinal peptides market revenues, 2010 - 2018 (USD Million)4.1.9 Renal 4.1.9.1 Global renal pipeline drugs analysis, number of trials, 2009 - 2012 4.1.9.2 Global renal peptides market revenues, 2010 2018 (USD Million) 4.1.10 Respiratory 4.1.10.1 Global respiratory pipeline drugs analysis, number of trials, 2009 - 2012 4.1.10.2 Global respiratory peptides market revenues, 2010 2018 (USD Million) 4.1.11 Pain 4.1.11.1 Global pain pipeline drugs analysis, number of trials, 2009 - 2012 4.1.11.2 Global pain peptides market revenues, 2010 - 2018 (USD Million) 4.1.12 Others 4.1.12.1 Global other pipeline drugs analysis, number of trials, 2009 - 2012 4.1.12.2 Global other peptides market revenues, 2010 2018 (USD Million) 8. Chapter 5 Global Peptide Therapeutics Market, by Route of Administration 5.1 Introduction 5.1.1 Global peptide therapeutics market revenues, by route of administration, 2010 2018 (USD Million) 5.1.2 Methods of delivery for peptide drugs 5.2 Parenteral Route 5.2.1 Global peptide therapeutics market revenues, by parenteral route of administration, 2010 - 2018 (USD Million) 5.3 Oral Route 5.3.1 Global peptide therapeutics market revenues, by oral route of administration, 2010 - 2018 (USD Million) 5.4 Pulmonary Route 5.4.1 Global peptide therapeutics market revenues, by pulmonary route of administration, 2010 - 2018 (USD Million) 5.5 Mucosal Route 5.5.1 Global peptide therapeutics market revenues, by mucosal route of administration, 2010 - 2018 (USD Million) 5.6 Others (Intradermal & Nasal) 5.6.1 Global peptide therapeutics market revenues, by other routes of administration, 2010 - 2018 (USD Million) Chapter 6 Peptide Therapeutics Market Generic & Innovative Segments 6.1 Introduction 6.1.1 Global peptide therapeutics market, by types revenues, 2010 - 2018 (USD million) 6.2 Peptide Therapeutics Innovative market 6.2.1 Global innovative peptide therapeutics market revenues, 2010 - 2018 (USD Million